Medicare Enrolled

Dr. Gene Zitser, M.D.

Neurology · Oakland Gardens, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
21604 UNION TPKE, Oakland Gardens, NY 11364
7184653200
Registered in NPPES since 2006
NPI: 1710924964 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zitser from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zitser? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zitser

Dr. Gene Zitser is a neurology specialist in Oakland Gardens, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zitser performed 1,209 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Zitser received a total of $32,987 from 79 pharmaceutical and/or device companies across 1072 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zitser is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 25% volume in NY $32,987 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,209
Medicare services
Top 25% in NY for neurology
Not available
Unique patients (not deduplicated)
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
462 $82 $154
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
141 $88 $117
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
82 $214 $405
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $143 $204
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
49 $47 $68
Vestibular function test with thermal irrigation
A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function.
42 $28 $111
Balance testing with recording
A procedure to evaluate balance function by recording the results during testing.
42 $71 $149
Vestibular function test using rotating chair
This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability.
42 $20 $146
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
42 $234 $317
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
39 $220 $299
Autonomic nervous system testing, heart rate response
This test evaluates the function of the autonomic nervous system by measuring how your heart rate responds to breathing exercises and changes in body position.
38 $41 $161
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
38 $45 $165
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
34 $96 $145
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
28 $155 $259
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $50 $81
Complete ultrasound of brain blood flow
An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation.
23 $242 $357
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
15 $189 $247
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
12 $254 $338
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$32,987
Total received (2018-2024)
Avg $4,712/year across 7 years
Top 14% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,072
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,566
2023
$3,174
2022
$3,150
2021
$3,568
2020
$3,600
2019
$3,215
2018
$13,714

Payments by company (2024)

ABBVIE INC.
$500
Neurelis, Inc.
$395
Neurocrine Biosciences, Inc.
$347
Teva Pharmaceuticals USA, Inc.
$319
PFIZER INC.
$155
Eisai Inc.
$115
Medtronic, Inc.
$100
UCB, Inc.
$95
ACADIA Pharmaceuticals Inc
$95
Grifols USA, LLC
$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$77
ARGENX US, INC.
$55
Amneal Pharmaceuticals LLC
$46
Novartis Pharmaceuticals Corporation
$39
MDD US Operations, LLC
$25
TG Therapeutics, Inc.
$24
Celgene Corporation
$23
SCILEX PHARMACEUTICALS INC.
$23
Amgen Inc.
$22
Lundbeck LLC
$18
Valinor Pharma, LLC
$16
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$11,549
Teva Pharmaceuticals USA, Inc.
$2,390
UCB, Inc.
$2,222
Allergan, Inc.
$1,378
AbbVie Inc.
$1,095
Biogen, Inc.
$1,089
Neurocrine Biosciences, Inc.
$1,068
ABBVIE INC.
$828
GENZYME CORPORATION
$797
Neurelis, Inc.
$763
Eisai Inc.
$757
PFIZER INC.
$670
SK Life Science, Inc.
$554
US WorldMeds, LLC
$445
Adamas Pharmaceuticals, Inc.
$402
ACADIA Pharmaceuticals Inc
$396
Novartis Pharmaceuticals Corporation
$366
Collegium Pharmaceutical, Inc.
$317
Amgen Inc.
$303
Celgene Corporation
$298
Scilex Pharmaceuticals Inc.
$289
Lundbeck LLC
$288
Avanir Pharmaceuticals, Inc.
$282
Harmony Biosciences LLC
$265
Lilly USA, LLC
$253
EMD Serono, Inc.
$210
Grifols USA, LLC
$206
Bausch Health US, LLC
$203
Allergan Inc.
$200
Neos Therapeutics, LP
$186
AbbVie, Inc.
$181
EISAI INC.
$176
Biohaven Pharmaceuticals, Inc.
$169
Amneal Pharmaceuticals LLC
$161
SCILEX PHARMACEUTICALS INC.
$160
JAZZ PHARMACEUTICALS INC.
$159
Medtronic, Inc.
$157
Sunovion Pharmaceuticals Inc.
$143
Biohaven Pharmaceutical Holding Company Ltd.
$134
Corium, LLC
$118
Impax Laboratories, Inc.
$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$77
HARMONY BIOSCIENCES LLC
$74
Boston Scientific Corporation
$64
Medtronic USA, Inc.
$62
Acorda Therapeutics, Inc
$56
ARGENX US, INC.
$55
Jazz Pharmaceuticals Inc.
$53
Alexion Pharmaceuticals, Inc.
$47
ITI, Inc.
$46
Aprecia Pharmaceuticals, LLC
$44
Kowa Pharmaceuticals America, Inc.
$42
RedHill Biopharma Inc.
$40
MDD US Operations, LLC
$39
Avion Pharmaceuticals
$39
Daiichi Sankyo Inc.
$37
Arbor Pharmaceuticals, Inc.
$34
Assertio Therapeutics, Inc.
$33
Merck Sharp & Dohme Corporation
$33
AQUESTIVE THERAPEUTICS, INC.
$32
Sumitomo Pharma America, Inc.
$29
TG Therapeutics, Inc.
$24
TG THERAPEUTICS, INC.
$24
CSL Behring
$22
E.R. Squibb & Sons, L.L.C.
$22
GRT US Holding, Inc.
$20
Zyla Life Sciences, Inc.
$20
CATALYST PHARMACEUTICALS, INC.
$20
Zyla Life Sciences
$20
Shire North American Group Inc
$20
Horizon Therapeutics plc
$19
Egalet US Inc
$19
Upsher-Smith Laboratories LLC
$18
LivaNova USA, Inc.
$18
Valinor Pharma, LLC
$16
Otsuka America Pharmaceutical, Inc.
$14
Promius Pharma LLC
$14
Virtus Pharmaceuticals LLC
$12
Forte Bio-Pharma LLC
$11
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Adzenys XR-ODT · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CAMBIA · CAPLYTA · COMIRNATY · COPAXONE · Cenobamate · Cotempla XR-ODT · Dhivy · Duopa · EMGALITY · EPIDIOLEX · FIRDAPSE · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · General - Pain Management · Gocovri · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LYRICA · Leqembi · Levorphanol · MIGRANAL · MOVANTIK · MYOBLOC · Mavenclad · Morphabond ER · Movantik · NALOCET · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · QELBREE · QUILLICHEW ER · QULIPTA · Qutenza · RAYOS · REXULTI · REYVOW · RYTARY · Rebif · SPRIX · SUNOSI · SYMPAZAN · Seglentis · Spritam · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART HYTRULO · Vimpat · WELLBUTRIN · Wakix · XTAMPZA · XTAMPZAER · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Oakland Gardens?
Compare neurologists in the Oakland Gardens area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
1,223
County median income
$84,961
Nearest hospital to ZIP centroid (approximate)
CREEDMOOR PSYCHIATRIC CENTER
1.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zitser is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zitser experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Zitser performed 462 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zitser receive payments from pharmaceutical companies?
Yes. Dr. Zitser received a total of $32,987 from 79 companies across 1,072 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zitser's costs compare to other neurologists in Oakland Gardens?
Dr. Zitser's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zitser) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →